A transitional B-cell cytokine biomarker for risk stratifying renal transplant patients with borderline rejection.
A transitional B-cell cytokine biomarker for risk stratifying renal transplant patients with borderline rejection. Kidney Int. 2023 04; 103(4):658-660.